Currently the price is 68,49$, In this post we are going to talk about the listed company Global Blood Therapeutics Inc, its leaders are Brian Cathers (Chief Scientific Officer), Jeffrey S. Farrow (Chief Financial & Accounting Officer), Nazila Habibizad (Senior Vice President-Operations), Ted W. Love (President, Chief Executive Officer & Director), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 68,48$ moving between 68,47$ and 68,49$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
